-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colon-cancer-gene-profiling_disposition-comments.pdf
December 14, 2012 - Given what
we know about traditional markers, particularly tumor grade, it is almost
certain that patients … Response is generally reserved for metastatic disease where actual tumor
measurements are possible. … #5 KI Background P 2 . . . patients with MSI-H tumors are excluded. Add the word tumors. … Public Agendia Background P.3 Tumor Heterogeneity (comment) Please note that the impact of tumor
heterogeneity … issue of ASCO Post published a brief summary of
data from this study that were presented at ASCO's GI Cancers
-
effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-decision-aid.pdf
March 01, 2016 - Is Lung Cancer Screening
Right for Me?
What is lung cancer? … These cells can form a tumor and can spread to other parts of the body. … » Lung cancer is the leading cause of
cancer death in the United States. … lung cancer:
3 lung cancer deaths will be prevented.
18 people will die of lung cancer. 21 people … Lung cancer
screening is done to find lung cancer before it has spread.
-
effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/03.html
June 08, 2018 - Home
Consumers
Clinically Localized Prostate Cancer
Prostate Cancer
Archived … This short video will tell you about the prostate gland, where it is located, and what happens when a tumor … A small tissue mass is then shown inside the prostate (a tumor). … The tumor grows to push against the outer wall of the prostate, forcing the wall to bulge against the … The tumor then expands outside the prostate, covering parts of the rectum.
-
effectivehealthcare.ahrq.gov/health-topics/male-breast-cancer
-
effectivehealthcare.ahrq.gov/health-topics/prostate-cancer-screening
-
effectivehealthcare.ahrq.gov/health-topics/cervical-cancer-screening
-
effectivehealthcare.ahrq.gov/health-topics/bile-duct-cancer
-
effectivehealthcare.ahrq.gov/products/cancer-decision-support-tools/research
December 23, 2014 - Structured Abstract
Background
Many health decisions about screening and treatment for cancers involve … It is unclear whether the effectiveness of decision aids for decisions related to cancers differs by … people's average risk of cancer or by the content and format of the decision aid. … We predefined three population groups of interest based on risk or presence of cancer (average cancer … risk, high cancer risk, early cancer).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-draft-report.pdf
October 31, 2023 - all gastrointestinal
malignancies.1 However, its incidence has risen steadily by two to three percent … carcinoma of the anus (SCCA) is by far the most common histology,
accounting for over 90 percent of anal malignancies … proton beam radiotherapy, and de-escalation of radiation dosing for appropriate stages.6 More
advanced tumors … myelosuppression, gastrointestinal
toxicity, such as diarrhea, vomiting, and bowel
obstruction, secondary malignancy … Efficacy of capecitabine versus 5-
fluorouracil in colorectal and gastric
cancers: a meta-analysis of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
March 25, 2012 - “Colorectal Neoplasms” (mh) OR ((colorectal OR colon) AND (neoplasm* OR cancer OR
carcinoma)) AND … OR ((ovarian OR breast OR colorectal
OR colon OR endometrial) AND (cancer OR cancers OR carcinoma OR … #59 ‘colorectal neoplasms’/exp OR (colorectal OR ‘colon’/exp OR intestinal AND
(‘neoplasm’/exp OR … ‘neoplasms’/exp OR ‘cancer’/exp OR ‘carcinoma’/exp)) AND
[humans]/lim AND [english]/lim AND [embase] … /lim
#60 #17 AND #59
#61 #56 AND #60
Ovarian Cancer
#61 ‘ovarian’/exp AND (‘neoplasm’/exp OR
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
October 27, 2015 - nonmuscle invasive bladder cancer. … On one end of the spectrum are
patients with low grade noninvasive tumors
that rarely develop tumors … implies that cystoscopy is
the gold standard for the identification and
surveillance of urothelial malignancies … related to the pre-test probability of a
urothelial malignancy as AHRQ has done
for the progression … How often will a subsequent work up in
the setting of persistent hematuria reveal a
urothelial malignancy
-
effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
February 24, 2016 - and malignant disease (many
studies included only tumors confirmed to be
cancer). … tumors in the cohort. … applicability
to clinical decision making and the vast majority of patients presenting
with renal cortical neoplasms … The main
point is that larger tumors are associated with
malignancy, and that the OR of 1.3 gives a … who proceeds to surgery as patient or tumor
characteristics (i.e. male sex, larger tumors)
influence
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_disposition-comments.pdf
December 01, 2011 - “Tumor volume” is probably the wrong
search term. … We did not
include % of cores in tumor volume. … incidence after the
introduction of PSA-based screening is
among low-stage tumors. … in lieu of locally advanced cancers. … integral dose results in
detectable clinical differences----presumably
in side effects and second malignancies-over
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
February 01, 2006 - Layout 1
Background
Breast cancer is the second most common
malignancy in women. … If a noninvasive diagnostic test
were available that could accurately
exclude malignancy, many women … , each would miss some
cancers. … PET scan, about 924 women would have
avoided an unnecessary biopsy, but 76 women
would have missed cancers … negative
US, about 950 women would have avoided an
unnecessary biopsy, but 50 women would have
missed cancers
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
March 11, 2010 - Introduction p. 11 some of these tumor types aren’t “basic” We have removed the word “basic”. … Diagnoses of malignancy on core-needle
biopsy that cannot be confirmed on open biopsy are
assumed to … Most such tumors would
probably be classified as “invasive” in most of the
studies. … Results The wide range of prevalence of malignancy from 15% to 68.9%
suggests to me that the 15% is … Results p. 50 the evidence seems to suggest a risk of malignancy of much
less than 8%.
-
effectivehealthcare.ahrq.gov/products/pediatric-cancer-survivorship
June 24, 2020 - Disparities and Barriers for Pediatric Cancer Survivorship Care
Timeline
June 24, 2020 … June 24, 2020
Research Protocol
Disparities and Barriers for Pediatric Cancer … March 01, 2021
Technical Brief
Disparities and Barriers to Pediatric Cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-survivor-care-transition_research-protocol.pdf
March 27, 2013 - Search "Survivors"[Mesh] OR survivorship OR survivor Filters: Humans; English 498,795
#10 Search "Neoplasms … Search 23257892[uid] 1
#2 Search "Survivors"[Mesh] OR survivorship OR survivor 771137
#3 Search "Neoplasms … #12 Search (#1 AND #9) 0
#13 Search (#1 AND #9) Schema: all 0
Search (("Survivors"[MAJR] AND "Neoplasms … late effects of treatment, second cancers, and poor quality of life, to provide a knowledge base
regarding … optimal followup care and surveillance of cancers, and to optimize health after cancer
treatment.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_disposition-comments.pdf
May 24, 2013 - They
vary by liver function, performance status, and
tumor stage. … Patients with low tumor burden (typically < 3
tumors all less than 3 cm) are offered
percutaneous/operative … If they have more
advanced disease (intermediate-staged HCC) with
multifocal tumors or large tumors … Childs C patients
typically are not candidates for cancer directed
therapies with rare exception. … Childs
C patients typically are not candidates for cancer
directed therapies with rare exception.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-equity-protocol.pdf
January 01, 2020 - incidence,
advanced breast cancer,
breast cancer mortality,
and all-cause mortality,
quality-of-life … Breast cancer screening
4. Cervical cancer screening
5. Colorectal cancer screening
6. … / or exp colorectal neoplasms/ or exp lung neoplasms/ or
uterine cervical neoplasms/
25 exp Obesity … / or exp colorectal neoplasms/ or exp lung neoplasms/ or
uterine cervical neoplasms/
25 exp Obesity … / or exp colorectal neoplasms/ or exp lung neoplasms/ or
uterine cervical neoplasms/
25 exp Obesity
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
November 12, 2013 - (breast, colon,
lung and prostate), and according to high prevalence versus rare cancers. … modified to the correct terminology
for CINAHL, PsycINFO, EMBASE, and any other databases searched:
("Neoplasms … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR
precancerous OR hypertrophy … and after”[tiab] or interrupted time*[tiab] or time
serie*[tiab] or intervention*[tiab]))) AND (("Neoplasms … "[Mesh] OR cancer OR cancers OR
neoplasm* OR malignan* OR premalignan* OR precancerous))
Filters:Publication